Sign up to save your podcasts
Or
Share Under the microscope: Resmed (ASX:RMD) - Derek Jellinek, Senior Analyst
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Under the microscope: Resmed (ASX:RMD) - Derek Jellinek, Senior Analyst
Morgans Senior Analyst Derek Jellinek discusses RMD 3Q results and strong resilience shown across the core business and incremental gains from COVID-19 induced demand for ventilators.
View all episodes
By Morgans Financial LimitedMorgans Senior Analyst Derek Jellinek discusses RMD 3Q results and strong resilience shown across the core business and incremental gains from COVID-19 induced demand for ventilators.